COVID-19

How can we make enough vaccine for 2 billion people?

Laboratory technicians of biotechnology company mAbxience are seen as they work, amid the outbreak of the coronavirus disease (COVID-19), in Buenos Aires, Argentina August 13, 2020. REUTERS/Agustin Marcarian - RC29DI9TTRUD

Fair access to a vaccine is a vital part of the vaccination process. Image: REUTERS/Agustin Marcarian

Harry Kretchmer
Senior Writer, Formative Content
Share:
Our Impact
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

Have you read?
Coronavirus vaccine candidates
There are a number of different COVID-19 vaccines in development. Image: Nature
Discover

What is the World Economic Forum doing to manage emerging risks from COVID-19?

The COVAX project aims to make 2 billion doses available to the world’s poorest people.
The COVAX project aims to make 2 billion doses available to the world’s poorest people. Image: Gavi
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19Pandemic Preparedness and ResponseGlobal HealthGlobal GovernancePrecision Medicine
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Here’s what to know about the new COVID-19 Pirola variant

Lora du Moulin and Charlotte Edmond

October 11, 2023

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum